WO2016006342A1 - 注射針 - Google Patents
注射針 Download PDFInfo
- Publication number
- WO2016006342A1 WO2016006342A1 PCT/JP2015/065023 JP2015065023W WO2016006342A1 WO 2016006342 A1 WO2016006342 A1 WO 2016006342A1 JP 2015065023 W JP2015065023 W JP 2015065023W WO 2016006342 A1 WO2016006342 A1 WO 2016006342A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- needle
- length
- central axis
- needle tube
- grinding
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3286—Needle tip design, e.g. for improved penetration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
Definitions
- the present invention relates to an injection needle that reduces the risk of tissue damage during injection, and more particularly to an injection needle that can be used for cosmetic surgery, ophthalmic surgery, and the like.
- Patent Document 1 proposes a device for intravitreal injection.
- the device for intravitreal injection of Patent Document 1 is a syringe having a proximal end and a distal end and a cylinder having a volume of 1 mL or less and containing an injection solution, and the solution is contained in the cylinder.
- the injection administration in the above-mentioned ophthalmic surgery causes fear for the patient.
- bacterial endophthalmitis is caused by bacteria entering the wound.
- risks such as the possibility of causing serious visual impairment.
- the device for intravitreal injection in Patent Document 1 describes using a 30-gauge cannula and coating with silicone, but the present situation is that it has not yet solved the above-mentioned risk of vitreous injection. It is.
- tissue damage due to syringes is also a problem in the field of cosmetic surgery.
- An object of the present invention is to provide an injection needle that can solve the problems based on the above-described conventional technology and reduce the risk of tissue damage during injection.
- the present invention provides an injection needle in which a needle tip is provided by forming at least two grinding surfaces after forming a first grinding surface at the tip of a needle tube.
- a needle tip is provided by forming at least two grinding surfaces after forming a first grinding surface at the tip of a needle tube.
- the surface that intersects perpendicularly to the surface and includes the central axis of the needle tube is the center surface, there is no needle tip on the center surface, and the first grinding surface and the at least two grinding surfaces are formed.
- the length (A) in the central axis direction of the blade surface is 0.6 to 2.2 mm
- the outer diameter (L) of the needle tube is 0.18 to 0.6 mm
- the needle has a length (A) value of 0.265 to 0.325.
- the grinding surface farthest from the needle tip among the grinding surfaces is first ground.
- the surface and other grinding surfaces are the second grinding surface and the third grinding surface
- the angle ⁇ between the first grinding surface and the central axis of the needle tube, the second grinding surface and the central axis of the needle tube, And the angle ⁇ between the third grinding surface and the central axis of the needle tube is an injection needle having a relationship of ⁇ ⁇ , ⁇ ⁇ , and ⁇ ⁇ ⁇ , and the outer diameter of the needle tube L
- the length of the first grinding surface in the central axis direction is A
- the length of the second grinding surface is C 1
- the length of the third grinding surface is C 2.
- the injection needle of the present invention can be used for at least one of retrobulbar administration and subtenon administration.
- the risk of tissue damage at the time of injection can be reduced, and it can be suitably used for cosmetic surgery and ophthalmic surgery.
- (A) is a top view of the injection needle of the embodiment of the present invention
- (b) is a left side view of the injection needle of the embodiment of the present invention
- (c) is of the embodiment of the present invention. It is a right view of an injection needle.
- (A) ⁇ (c) is a side view of the injection needle of an embodiment of the present invention
- (a) is a side view as seen so that the first ground surface is horizontal
- (b) It is the side view seen so that the 2nd grinding surface may become horizontal
- (c) is the side view seen so that the 3rd grinding surface may become horizontal.
- FIG. 1 (a) is a plan view of an injection needle according to an embodiment of the present invention
- FIG. 1 (b) is a left side view of the injection needle according to an embodiment of the present invention
- FIG. It is a right view of the injection needle of an embodiment of the present invention.
- the injection needle 10 of the present embodiment has a blade surface 14 formed at the tip of a needle tube 12.
- the blade surface 14 is formed of a first grinding surface 14a, a second grinding surface 14b, and a third grinding surface 14c that are farthest from the needle tip 18.
- the injection needle 10 has a needle tip 18 perpendicular to the first grinding surface 14a on the blade surface 14 and on the central surface 20 including the central axis C of the needle tube 12 (see FIGS. 1B and 1C). It is formed so as not to exist.
- the length A of the blade surface 14 in the central axis direction Dc is 0.6 to 2.2 mm.
- the angle of the blade surface 14 can be increased. Thereby, when delivering a chemical
- the length A of the blade surface 14 in the central axis direction Dc is preferably 0.62 to 0.90 mm.
- the target tissue is a part of a living body to be injected, and is not particularly limited.
- the target tissues are skin, vitreous body, anterior chamber of eyeball, vitreous cavity, fundus and tenon capsule.
- the needle tube 12 is 23 gauge to 34 gauge.
- the outer diameter (L) of the needle tube 12 is 0.18 mm to 0.6 mm.
- the needle tube 12 is preferably 32 gauge to 33 gauge.
- the outer diameter (L) of the needle tube 12 is 0.20 mm to 0.23 mm. More preferably, it is 32.5 gauge.
- Needle tube 12 is made of, for example, steel materials including stainless steel, non-ferrous metal materials such as aluminum, copper and titanium, heat resistant materials such as nickel, cobalt and molybdenum, low melting point metals such as lead and tin, gold, silver and platinum. It is comprised using such noble metal materials and these alloys.
- the shape of the needle tube 12 is not limited to a straight tube, but may be a cylindrical body having a tapered shape toward the distal end or the proximal end. Moreover, it may become a taper shape from the middle of the blade surface 14.
- the blade surface 14 of the needle tube 12 may be coated with silicone to reduce resistance during injection.
- the injection needle 10 is shaped to project the blade 16 formed by the third ground surface 14c by forming the blade surface 14 into the shape described above.
- the portion that hits the target tissue is close to a line instead of a point, so that the force applied to the target tissue is dispersed.
- the target tissue can be smoothly punctured and pain can be reduced.
- the direction in which the blade 16 projects is not particularly limited, and may be the direction of the second grinding surface 14b.
- the needle tip 18 may be positioned in the left or right direction with respect to the center plane 20.
- the shortest distance S between the needle tip 18 and the center surface 20 is preferably 3 to 20% of the maximum outer diameter in the minor axis direction Ds (see FIG. 1A) of the blade surface 14 and is 5 to 15%. More desirable.
- the shortest distance S between the needle tip 18 and the center surface 20 is preferably 8 to 100 ⁇ m, and more preferably 8 to 35 ⁇ m.
- the shortest distance S between the needle tip 18 and the center plane 20 is smaller than the above range, the portion that first contacts the target tissue becomes closer to the point, and thus the force applied to the target tissue cannot be sufficiently dispersed. As a result, the target tissue cannot be punctured smoothly, and the patient feels pain. If the shortest distance S between the needle tip 18 and the center surface 20 is larger than the above range, the portion where the blade 16 contacts the target tissue becomes large, so the needle tip 18 is difficult to penetrate the target tissue, and puncture is smooth. May not be possible, and the pain experienced by the patient may increase.
- FIG. 2 (a) to 2 (c) are side views of the injection needle according to the embodiment of the present invention.
- FIG. 2 (a) shows the first ground surface 14a horizontal
- FIG. 2 (c) shows the side surface of the third ground surface 14c viewed so that the second ground surface 14b is horizontal.
- the first ground surface 14 a has an arbitrary angle ⁇ with respect to the central axis C of the needle tube 12 as shown in FIG.
- the second grinding surface 14 b has an arbitrary angle ⁇ with respect to the central axis C of the needle tube 12.
- the third ground surface 14 c has an arbitrary angle ⁇ with respect to the central axis C of the needle tube 12.
- the angle ⁇ and the angle ⁇ are larger than the angle ⁇ , and the angle ⁇ and the angle ⁇ are different from each other. That is, regarding the angle, angle ⁇ ⁇ angle ⁇ , angle ⁇ , angle ⁇ ⁇ angle ⁇ .
- the shortest distance S from the center surface 20 including the center axis C of the needle tube 12 is the minor axis direction Ds of the blade surface 14 (FIG. 1 ( It is more desirable to set it to be 3 to 20%, more preferably 5 to 15% of the maximum outer diameter of a)). Further, it is desirable to set the shortest distance S (see FIG. 1A) between the needle tip 18 and the center plane 20 to be 8 to 100 ⁇ m, more preferably 8 to 35 ⁇ m.
- the shortest distance S is smaller than the above range, the portion that first contacts the target tissue is closer to the point, and thus the force applied to the target tissue cannot be sufficiently dispersed. As a result, the target tissue cannot be punctured smoothly, and the patient feels pain.
- the shortest distance S is larger than the above range, the portion where the blade 16 contacts the target tissue becomes large, so that the needle tip 18 is difficult to penetrate the skin, the puncture cannot be performed smoothly, and the patient suffers from pain. May increase.
- the length length of C 2 in the central axis direction Dc of the central axis direction Dc length C 1 and a third grinding face 14c of the second grinding face 14b is in the central axis direction Dc of the blade surface 14 length A It is desirable to set it to be 20% or more and 80% or less. If less than 20% of the length A of the second grinding face 14b axial direction Dc length C 1 and the length C 2 is the central axis direction Dc of the central axis direction Dc of the third grinding face 14c of the subject The range in which the tissue can be cut becomes smaller, making it harder to stab.
- the length C 1 of the central axis direction Dc of the second grinding surface 14b is longer than the length C 2 in the central axis direction Dc of the third grinding face 14c but it is not limited thereto, may be longer than the length C 1 of the length C 2 in the central axis direction Dc of the third grinding face 14c axial direction Dc of the second grinding face 14b. Even in this case, the same effect as that of the injection needle 10 shown in FIG.
- a 23 gauge to 34 gauge needle tube 12 is used, and the needle tip 18 is not present on the central plane 20 including the central axis C of the needle tube 12.
- the target tissue can be smoothly punctured, and the length A in the central axis direction Dc of the blade surface 14 is set to 0.6 to 2.2 mm.
- the outer diameter (L) of the needle tube By setting the value of the length (A) in the central axis direction Dc of the blade surface to 0.265 to 0.325, the puncture of the target tissue can be made smooth and the depth of entry can be reduced.
- the injection needle 10 can be suitably used for ophthalmic surgery and the like, and can suppress, for example, the risk of bacterial infection that becomes a problem in vitreous injection and the generation of pain that becomes a problem in subconjunctival administration. Furthermore, it is possible to reduce the risk of bleeding that becomes a problem in post-bulb administration and sub-Tenon capsule administration, and the injection needle 10 can be suitably used for post-ball administration and sub-Tenon capsule administration.
- the outer diameter of the needle tube 12 and (L) a first grinding face 14a length A of the central axis direction Dc, the central axis direction Dc length C 1 and a third grinding face 14c of the second grinding face 14b in the central axis direction Dc the relationship between the length C 2, the outer diameter (L) / the 0.265 value of length (a) ⁇ 0.325 of the needle tube 12, the outer diameter of the needle tube 12 (L) /
- the value of the length (C 1 ) is 0.45 to 0.52
- the value of the outer diameter (L) of the needle tube 12 / the length (C 2 ) is 0.83 to 1.2. preferable.
- the value of A is 0.62 to 0.9
- the value of L / A is 0.28 to 0.30
- the value of L / C 1 is 0.5 to 0.00. 52
- the value of L / C 2 is 0.9 to 1.1.
- Specific examples of the injection needle of the present invention are shown in Table 1 below.
- the numerical values shown in Table 1 below are the gauge of the needle tube 12, the outer diameter L of the needle tube 12, the length A in the central axis direction Dc of the blade surface 14, and the length C in the central axis direction Dc of the second grinding surface 14b. 1 and the relationship between the length C 2 in the central axis direction Dc of the third grinding face 14c is obtained by the table. If it is set as the structure shown in following Table 1, it is possible to manufacture the injection needle which concerns on this invention.
- the present invention is basically configured as described above. As mentioned above, although the injection needle of this invention was demonstrated in detail, this invention is not limited to the said embodiment, Of course, in the range which does not deviate from the main point of this invention, various improvement or a change may be carried out. .
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
特許文献1の硝子体内注射用の装置には、30ゲージのカニューレを用いること、シリコーン被覆することが記載されているが、硝子体注射際の上述のリスクを解消するには至っていないのが現状である。さらに、注射器による組織損傷は美容整形の分野でも課題となっている。
本発明の注射針は、球後投与およびテノン嚢下投与のうち、少なくとも一方に用いることができる。
図1(a)は、本発明の実施形態の注射針の平面図であり、図1(b)は、本発明の実施形態の注射針の左側面図であり、図1(c)は、本発明の実施形態の注射針の右側面図である。
図1(a)に示すように、本実施形態の注射針10は、針管12の先端に刃面14が形成されている。刃面14は、針先18から最も離れた第一研削面14a、第二研削面14bおよび第三研削面14cから形成されている。さらに、注射針10は、刃面14において針先18が第一研削面14aに垂直に交わり、かつ針管12の中心軸線C(図1(b)、(c)参照)を含む中心面20上に存在しないように形成されている。
ここで、対象組織とは、注射する対象となる生体の部位のことであり、特に限定されるものではない。例えば、対象組織は、皮膚、硝子体、眼球の前眼房、硝子体腔、眼底およびテノン嚢等である。
さらに、前記針管の外径(L)/前記刃面の中心軸方向Dcの長さ(A)の値は0.265~0.325であるように設定される。この値より大きい場合、対象物への穿刺が困難になり、この値より小さい場合は刃面が長すぎて対象物を損傷するリスクが大きくなる 。なお、より好ましくはL/A=0.28~0.30である。
なお、針管12の形態は、直管のみでなく、先端または基端に向けてテーパー形状である筒体であってもよい。また、刃面14の途中からテーパー形状となるものであってもよい。針管12の刃面14は、注射時の抵抗を減らすためにシリコーンで被覆してもよい。
図1(a)に示す注射針10では、第二研削面14bの中心軸方向Dcの長さC1は、第三研削面14cの中心軸方向Dcの長さC2よりも長くなっているが、これに限定されるものではなく、第三研削面14cの中心軸方向Dcの長さC2を第二研削面14bの中心軸方向Dcの長さC1よりも長くしてもよい。この場合でも、図1(a)に示す注射針10と同様の効果を得ることができる。
本発明の注射針の具体例を下記表1に示す。下記表1に記載の数値は、それぞれ、針管12のゲージ、針管12の外径L、刃面14の中心軸方向Dcの長さA、第二研削面14bの中心軸方向Dcの長さC1および第三研削面14cの中心軸方向Dcの長さC2の関係を表にしたものである。下記表1に示す構成とすれば、本発明に係る注射針を製造することが可能である。
12 針管
14 刃面
14a 第一研削面
14b 第二研削面
14c 第三研削面
16 刃
18 針先
20 中心面
22 あご部
A、C1、C2 長さ
C 中心軸
L 外径
S 最短距離
Claims (3)
- 針管の先端に最初の研削面を形成した後、さらに少なくとも2つの研削面を形成することによって針先が設けられた注射針において、
前記最初の研削面に垂直に交わり、かつ前記針管の中心軸線を含む面を中心面とした場合に、前記中心面上に針先がなく、
前記最初の研削面と前記少なくとも2つの研削面とで形成された刃面の中心軸方向の長さ(A)が0.6~2.2mmであり、
前記針管の外径(L)が0.18~0.6mmであって、
前記針管の外径(L)/前記長さ(A)の値が0.265~0.325であることを特徴とする注射針。 - 針管の先端に3つの研削面により刃面を形成することによって針先が設けられた注射針において、
前記研削面のうち前記針先から最も離れた研削面を第一研削面、その他の研削面を第二研削面および第三研削面とした場合に、前記第一研削面と前記針管の中心軸線との角度αと、前記第二研削面と前記針管の中心軸線との角度φと、前記第三研削面と前記針管の中心軸線との角度θとが、α<φ、α<θ、かつφ≠θの関係を有する注射針であって、
前記針管の外径をL、第一研削面の中心軸方向の長さをA、前記第二研削面の長さをC1、前記第三研削面の長さをC2とした場合に、
前記針管の外径(L)が0.18~0.6mm、前記針管の外径(L)/前記長さ(A)の値が0.265~0.325、前記針管の外径(L)/前記長さ(C1)の値が0.45~0.52、前記針管の外径(L)/前記長さ(C2)の値が0.83~1.2であることを特徴とする注射針。 - 球後投与およびテノン嚢下投与のうち、少なくとも一方に用いられることを特徴とする請求項1または2に記載の注射針。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016532485A JPWO2016006342A1 (ja) | 2014-07-08 | 2015-05-26 | 注射針 |
EP15819424.1A EP3167926A4 (en) | 2014-07-08 | 2015-05-26 | Injection needle |
US15/081,479 US10130777B2 (en) | 2014-07-08 | 2016-03-25 | Injection needle |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014140774 | 2014-07-08 | ||
JP2014-140774 | 2014-07-08 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/081,479 Continuation US10130777B2 (en) | 2014-07-08 | 2016-03-25 | Injection needle |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016006342A1 true WO2016006342A1 (ja) | 2016-01-14 |
Family
ID=55063984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/065023 WO2016006342A1 (ja) | 2014-07-08 | 2015-05-26 | 注射針 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10130777B2 (ja) |
EP (1) | EP3167926A4 (ja) |
JP (1) | JPWO2016006342A1 (ja) |
WO (1) | WO2016006342A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109890333A (zh) * | 2016-09-02 | 2019-06-14 | 爱瑞制药公司 | 植入物涂敷器 |
US10582914B2 (en) | 2016-01-15 | 2020-03-10 | Covidien Lp | Navigable endobronchial tool to access tissue outside a bronchus |
JP2021524295A (ja) * | 2018-05-17 | 2021-09-13 | ノボ・ノルデイスク・エー/エス | 研磨された尖頭を備える針カニューレ |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190008552A1 (en) * | 2017-07-05 | 2019-01-10 | Bruce H. Levin | Medical Instruments With Multi-Faceted Edges |
CN111712274A (zh) * | 2018-02-14 | 2020-09-25 | 泰尔茂株式会社 | 穿刺针 |
SE2050580A1 (en) * | 2020-05-19 | 2021-11-20 | Smartwise Sweden Ab | Endoluminal delivery cannula and assembly |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003511204A (ja) * | 1999-10-21 | 2003-03-25 | アルコン,インコーポレイティド | テノン下薬剤送出 |
JP2003290354A (ja) * | 2002-03-29 | 2003-10-14 | Terumo Corp | 注射針 |
JP2009508593A (ja) * | 2005-09-16 | 2009-03-05 | (オーエスアイ)アイテツク・インコーポレーテツド | 眼科用シリンジ |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR799455A (fr) * | 1935-03-15 | 1936-06-13 | Aiguille pour injections et applications thérapeutiques | |
US5752942A (en) * | 1996-06-20 | 1998-05-19 | Becton Dickinson And Company | Five beveled point geometry for a hypodermic needle |
FR2887153B1 (fr) * | 2005-06-20 | 2008-04-04 | Alain Villette | Aiguille d'injection preforante |
US20140296797A1 (en) * | 2011-11-04 | 2014-10-02 | Nipro Corporation | Injection needle |
WO2015114706A1 (ja) * | 2014-01-31 | 2015-08-06 | テルモ株式会社 | 医療用の穿刺針及び穿刺針の製造方法 |
-
2015
- 2015-05-26 JP JP2016532485A patent/JPWO2016006342A1/ja active Pending
- 2015-05-26 EP EP15819424.1A patent/EP3167926A4/en not_active Withdrawn
- 2015-05-26 WO PCT/JP2015/065023 patent/WO2016006342A1/ja active Application Filing
-
2016
- 2016-03-25 US US15/081,479 patent/US10130777B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003511204A (ja) * | 1999-10-21 | 2003-03-25 | アルコン,インコーポレイティド | テノン下薬剤送出 |
JP2003290354A (ja) * | 2002-03-29 | 2003-10-14 | Terumo Corp | 注射針 |
JP2009508593A (ja) * | 2005-09-16 | 2009-03-05 | (オーエスアイ)アイテツク・インコーポレーテツド | 眼科用シリンジ |
Non-Patent Citations (1)
Title |
---|
See also references of EP3167926A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10582914B2 (en) | 2016-01-15 | 2020-03-10 | Covidien Lp | Navigable endobronchial tool to access tissue outside a bronchus |
US11559290B2 (en) | 2016-01-15 | 2023-01-24 | Covidien Lp | Navigable endobronchial tool to access tissue outside a bronchus |
CN109890333A (zh) * | 2016-09-02 | 2019-06-14 | 爱瑞制药公司 | 植入物涂敷器 |
JP2019534063A (ja) * | 2016-09-02 | 2019-11-28 | エンビシャ セラピューティクス インコーポレイテッド | インプラントアプリケータ |
JP2021524295A (ja) * | 2018-05-17 | 2021-09-13 | ノボ・ノルデイスク・エー/エス | 研磨された尖頭を備える針カニューレ |
Also Published As
Publication number | Publication date |
---|---|
EP3167926A4 (en) | 2018-01-24 |
US20160206832A1 (en) | 2016-07-21 |
US10130777B2 (en) | 2018-11-20 |
JPWO2016006342A1 (ja) | 2017-04-27 |
EP3167926A1 (en) | 2017-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016006342A1 (ja) | 注射針 | |
US20200383965A1 (en) | Methods and devices for the treatment of ocular diseases in human subjects | |
US10492826B2 (en) | Short-bevel non-coring needle | |
US11071643B2 (en) | Ocular therapeutics tool | |
JP4025567B2 (ja) | 注射針 | |
CA2960975C (en) | Therapeutic agent delivery device with advanceable cannula and needle | |
US9682197B2 (en) | Systems and methods for performing an injection | |
JP2004518516A (ja) | 針カニューレ、針カニューレの製造方法および針カニューレの使用 | |
CN106038053A (zh) | 眼球后注药装置 | |
EP2247270B1 (en) | Needle for ophthalmic procedures | |
RU2327437C1 (ru) | Устройство для доставки лекарственных средств к заднему полюсу глаза и способ доставки лекарственных средств к заднему полюсу глаза | |
CN209499970U (zh) | 一种适于豚鼠凝胶注射的鼓膜穿刺针 | |
MX2023001752A (es) | Sistemas y metodos para administracion de farmaco al tejido ocular. | |
CN204337126U (zh) | 一种用于眼眶内、眼球周围及眼球后注射给药装置 | |
EP4374834A1 (en) | Ophthalmic injection assembly and injection device, and use method | |
JP2022512504A (ja) | 医療ベベルニードル | |
JP6133464B1 (ja) | 耳鼻科用注射針、鼓室内薬剤注入用注射針 | |
CN213666114U (zh) | 一种用于角膜基质内注射的针头 | |
US20160243316A1 (en) | Injection needle having varying caliber | |
JP2024528555A (ja) | 眼用注射アセンブリ、注射装置及び使用方法 | |
UA106972U (uk) | Спосіб малоінвазивної одномоментної хірургії при субмакулярному крововиливі та макулярній дірці, які спостерігаються у хворого в одному і тому ж оці | |
CN106267452A (zh) | 一种大流量输液针头 | |
RU74564U1 (ru) | Устройство для гидроделиминации коры стекловидного тела | |
Jankovic et al. | Regional anesthesia in ophthalmology | |
CN117260472A (zh) | 注射用的五斜面针管及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15819424 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016532485 Country of ref document: JP Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2015819424 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015819424 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |